Impact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma.

about

Impact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma.

Item

http://www.wikidata.org/entity/Q42211126

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of Preferentially Expre ...... s of Hepatocellular Carcinoma.

@en

Impact of Preferentially Expre ...... s of Hepatocellular Carcinoma.

@nl

type

Item

label

Impact of Preferentially Expre ...... s of Hepatocellular Carcinoma.

@en

Impact of Preferentially Expre ...... s of Hepatocellular Carcinoma.

@nl

prefLabel

Impact of Preferentially Expre ...... s of Hepatocellular Carcinoma.

@en

Impact of Preferentially Expre ...... s of Hepatocellular Carcinoma.

@nl

P1476

Impact of Preferentially Expre ...... s of Hepatocellular Carcinoma.

@en

P2093

Etsuro Hatano

http://www.w3.org/2001/XMLSchema#string

Goshi Shiota

http://www.w3.org/2001/XMLSchema#string

Hiroki Shimizu

http://www.w3.org/2001/XMLSchema#string

Junya Azumi

http://www.w3.org/2001/XMLSchema#string

Keita Kanki

http://www.w3.org/2001/XMLSchema#string

Kenji Oyama

http://www.w3.org/2001/XMLSchema#string

P2860

The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling

Gene expression profiling predicts clinical outcome of breast cancer

The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome

PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cells

PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia.

The promise of retinoids to fight against cancer.

Vitamin A, retinol, and carotenoids and the risk of gastric cancer: a prospective cohort study.

Retinoids in cancer therapy and chemoprevention: promise meets resistance.

P304

128-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000448137

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kan Toriguchi

Yohei Kono

P577

2016-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28611979

http://www.w3.org/2001/XMLSchema#string

P932

5465675

http://www.w3.org/2001/XMLSchema#string